The neurobehavioral underpinnings of pathological gambling are not well understood.
Insight might be gained by understanding pharmacological effects on the reward system in …

Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria,
published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for …

Objective In Parkinson disease (PD) patients, deep brain stimulation (DBS) of the subthalamic
nucleus (STN) may contribute to certain impulsive behavior during high‐conflict decisions. …

… data: van Eimeren, Ballanger, and Strafella. Drafting of the manuscript: van Eimeren, Ballanger…
Critical revision of the manuscript for important intellectual content: van Eimeren, Monchi, …

PSP is a pathologically defined neurodegenerative tauopathy with a variety of clinical
presentations including typical Richardson's syndrome and other variant PSP syndromes. A large …

Functional neuroimaging techniques provide important insight into the pathophysiology of
neurodegenerative disorders such as Parkinson's disease (PD) in-vivo. Recently, resting-state …

Background Progressive supranuclear palsy (PSP) is a neuropathologically defined disease
presenting with a broad spectrum of clinical phenotypes. Objective To identify clinical …

Background Complex visual hallucinations (VHs) occur in several pathologic conditions;
however, the neural mechanisms underlying these symptoms remain unclear. Although …

Deep brain stimulation of the subthalamic nucleus improves motor functions in patients
suffering from advanced Parkinson’s disease but in some patients, it is also associated with a …

There is evidence that the right dorsolateral prefrontal cortex (DLPFC) may play a certain
role in decision making related to reward value and time perception and, in particular, in the …